Home/Filings/4/0001209191-23-057974
4//SEC Filing

Patel Paresh 4

Accession 0001209191-23-057974

CIK 0001400810other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:39 PM ET

Size

16.3 KB

Accession

0001209191-23-057974

Insider Transaction Report

Form 4
Period: 2023-12-06
Patel Paresh
DirectorExecutive Chairman
Transactions
  • Other

    Common Stock

    2023-12-06$78.00/sh+5,000$390,000338,000 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $53.00Exp: 2029-01-15Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    Exercise: $40.00Exp: 2028-02-08Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    Exercise: $48.00Exp: 2030-01-16Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    Exercise: $70.00Exp: 2033-09-15Common (150,000 underlying)
    150,000
  • Common stock

    447,000
  • Common stock

    (indirect: By IRA)
    37,500
  • Common Stock

    10,000
  • Common Stock

    10,000
  • Stock Option (Right to Buy)

    Exercise: $40.00Exp: 2027-01-07Common (110,000 underlying)
    110,000
Footnotes (10)
  • [F1]The Reporting Person purchased 5,000 common shares for $78 per share in a secondary offering. The offering was part of an underwriten public offering of HCI Group, Inc. common shares.
  • [F10]The options were granted on September 15, 2023 and the options will vest, if ever, on the date on which the company stock value first equals or exceeds $80.00 for 20 consecutive trading days on the applicable exchange. If the above conditions are met, the options will be exercisable at an exercise price of $70.00 per share. The options will expire on September 15, 2033.
  • [F2]Shares held jointly with spouse.
  • [F3]Restricted stock grant of 40,000 shares effective January 16, 2020: Restrictions on 10,000 shares will lapse on each of January 16, 2021, January 16, 2022, January 16, 2023, and January 16, 2024. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 16, 2020.
  • [F4]Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
  • [F5]The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
  • [F6]The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. All options have vested and may be exercised at any time up to and including January 7, 2027.
  • [F7]The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. All options have vested and may be exercised at any time up to and including February 8, 2028.
  • [F8]The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. All options have vested and may be exercised at any time up to and including January 15, 2029.
  • [F9]The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. Of the 110,000 options, 82,500 have vested and the remaining 27,500 options will vest January 16, 2024. Once vested, the options may be exercised at any time up to and including January 16, 2030.

Issuer

HCI Group, Inc.

CIK 0001400810

Entity typeother

Related Parties

1
  • filerCIK 0001439934

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:39 PM ET
Size
16.3 KB